Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12

International Journal of Cancer

Volumn 80, Issue 2, 1999, Pages 324-333

  Fallarino, Francesca ^a   Uyttenhove, Catherine ^b   Boon, Thierry ^b   Gajewski, Thomas F ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; DENDRITIC CELL; MASTOCYTOMA; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNIZATION; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED DBA; OLIGOPEPTIDES; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 0033579865     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990118)80:2<324::AID-IJC25>3.0.CO;2-D     Document Type: Article

References (23)

1. BRICHARD, V.G., WARNIER, G., VAN PEL, A., MORLIGHEM, G., LUCAS, S. and BOON, T., Individual differences in the orientation of the cytolytic T cell responses against mouse tumor P815. Europ. J. Immunol., 25, 664-671 (1995).
2. DE PLAEN, E. and 15 OTHERS, Structure, chromosomal location, and expression of 12 genes of the MAGE family. Immunogenetics, 40, 360-369 (1994).
3. EYNON, E.E. and PARKER, D.C., Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. exp. Med., 175, 131-138 (1992).
4. FALLARINO, F., UYTTENHOVE, C., BOON, T. and GAJEWSKI, T.F., Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo. J. Immunol., 156, 1095-1100 (1996).
5. GABRILOVICH, D.I., CUNNINGHAM, H.T. and CARBONE, D.P., IL-12 and mutant p53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer. J. Immunother., 19, 414-418 (1997).
6. GAJEWSKI, T.F. and FALLARINO, F., Rational development of tumour antigen-specific immunization in melanoma. Ther. Immunol., 2, 211-225 (1997).
7. GAJEWSKI, T.F., RENAULD, J.-C., VAN PEL, A. and BOON, T., Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine anti-tumor cytolytic T lymphocytes in vitro. J. Immunol., 154, 5637-5648 (1995).
8. GAJEWSKI, T.F., UYTTENHOVE, C., FALLARINO, F. and BOON, T., Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J. Immunol., 156, 2909-2917 (1996).
9. HUANG, A.Y.C., GOLUMBEK, P., AHMADZADEH, M., JAFFEE, E., PARDOLL, D. and LEVITSKY, H., Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science, 264, 961-965 (1994).
10. LETHÉ, B., VAN DEN EYNDE, B., VAN PEL, A., CORRADIN, G. and BOON, T., Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide. Europ. J. Immunol. 22, 2283-2288 (1992).
11. NOGUCHI, Y., RICHARDS, E.C., CHEN, Y.T. and OLD, L.J., Influence of interleukin 12 on p53 peptide vaccination against Meth A sarcoma. Proc. not. Acad. Sci. (Wash.), 92, 2219-2223 (1995).
12. RAO, J.B., CHAMBERLAIN, R.S., BRONTE, V., CARROLL, M.W., IRVINE, K.R., MOSS, B., ROSENBERG, S.A. and RESTIFO, N.P., IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. J. Immunol., 156, 3357-3365 (1996).
13. SCHULER, G. and STEINMAN, R.M., Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. exp. Med., 186, 1183-1187 (1997).
14. - transplantation antigen P198: a point mutation generates a new antigenic peptide. J. exp. Med., 172, 35-45 (1990).
15. STEINMAN, R.M., KAPLAN, G., WITMER, M.D. and COHN, Z.A., Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of splenic dendritic cells, new surface markers, and maintenance in vitro. J. exp. Med., 149, 1-16 (1979).
16. TOES, R.E., OFFRINGA, R., BLOM, R.J., MELIEF, C.J. and KAST, W.M., Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc. nat. Acad. Sci. (Wash.), 93, 7855-7860 (1996).
17. TRINCHIERI, G., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immuno., 13, 251-276 (1995).
18. UYTTENHOVE, C., GODFRAIND, C., LETHÉ, B., AMAR-COSTESEC, A., RENAULD, J.-C., GAJEWSKI, T.F., DUFFOUR, M.-T., WARNIER, G., BOON, T. and VAN DEN EYNDE, B.J., The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen. Int. J. Cancer, 70, 349-356 (1997).
19. UYTTENHOVE, C., MARYANSKI, J. and BOON, T., Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J. exp. Med., 157, 1040-1052 (1983).
20. UYTTENHOVE, C., VAN SNICK, J. and BOON, T., Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. J. exp. Med., 152, 1175-1183 (1980).
21. VAN DEN EYNDE, B., LETHÉ, B., VAN PEL, A., DE PLAEN, E. and BOON, T., The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. exp. Med., 173, 1373-1384 (1991).
22. VAN PEL, A., VAN DER BRUGGEN, P., COULIE, P.G., BRICHARD, V.G., LETHÉ, B., VAN DEN EYNDE, B., UYTTENHOVE, C., RENAULD, J.-C. and BOON, T., Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145, 229-250 (1995).
23. WARNIER, G., DUFFOUR, M.T., UYTTENHOVE, C., GAJEWSKI, T.F., LURQUIN, C., HADDADA, H., PERRICAUDET, M. and BOON, T., Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A. Int. J. Cancer, 67, 303-310 (1996).